Sarah Weske
Duesseldorf, NW 40225, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Sphingosine-1-phosphate promotes osteogenesis by stimulating osteoblast growth and neovascularization in a vascular endothelial growth factor-dependent manner.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: August 18, 2023
Pharmacological elevation of sphingosine-1-phosphate by S1P lyase inhibition accelerates bone regeneration after post-traumatic osteomyelitis.
Journal: Journal of cellular and molecular medicine
Published: June 15, 2023
Sphingosine-1-Phosphate (S1P) Lyase Inhibition Aggravates Atherosclerosis and Induces Plaque Rupture in ApoE-/-Mice.
Journal: International journal of molecular sciences
Published: July 05, 2022
Cellular mechanisms and recommended drug-based therapeutic options in diabetic cardiomyopathy.
Journal: Pharmacology & therapeutics
Published: April 30, 2021
Agonist-induced activation of the S1P receptor 2 constitutes a novel osteoanabolic therapy for the treatment of osteoporosis in mice.
Journal: Bone
Published: January 16, 2019
Regulation of ABCA1-mediated cholesterol efflux by sphingosine-1-phosphate signaling in macrophages.
Regulation of ABCA1-mediated cholesterol efflux by sphingosine-1-phosphate signaling in macrophages.
Journal: Journal of lipid research
Published: July 16, 2018
Targeting sphingosine-1-phosphate lyase as an anabolic therapy for bone loss.
Journal: Nature medicine
Published: January 11, 2017
Defects of High-Density Lipoproteins in Coronary Artery Disease Caused by Low Sphingosine-1-Phosphate Content: Correction by Sphingosine-1-Phosphate-Loading.
Journal: Journal of the American College of Cardiology
Published: May 31, 2015
Last Updated: 09/26/2026